Pten gene mutations are seen in high grade, but not in low grade gliomas.

被引：0
|
作者：
Stenzel, TT
Rasheed, BKA
McLendon, RE
Parsons, R
Friedman, AH
Friedman, HS
Bigner, SH
机构：
[1] DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[3] DUKE UNIV,MED CTR,DEPT PEDIAT,DURHAM,NC 27710
[4] COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY
[5] COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY
来源：
CLINICAL CHEMISTRY | 1997年 / 43卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [41] IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas
    Tareq A. Juratli
    Matthias Kirsch
    Katja Robel
    Silke Soucek
    Kathrin Geiger
    Rüdiger von Kummer
    Gabriele Schackert
    Dietmar Krex
    Journal of Neuro-Oncology, 2012, 108 : 403 - 410
  • [42] IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas
    Juratli, Tareq A.
    Kirsch, Matthias
    Robel, Katja
    Soucek, Silke
    Geiger, Kathrin
    von Kummer, Ruediger
    Schackert, Gabriele
    Krex, Dietmar
    JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (03) : 403 - 410
  • [43] The silent phase of diffuse low-grade gliomas. Is it when we missed the action?
    Johan Pallud
    Laurent Capelle
    Luc Taillandier
    Mathilde Badoual
    Hugues Duffau
    Emmanuel Mandonnet
    Acta Neurochirurgica, 2013, 155 : 2237 - 2242
  • [44] Low Grade Gliomas. Can We Predict Tumour Behaviour from Imaging Features?
    Romanowski, C. A. J.
    Hoggard, N.
    Jellinek, D. A.
    Levy, David
    Wharton, S. B.
    Kotsarini, C.
    Batty, R.
    Wilkinson, I. D.
    NEURORADIOLOGY JOURNAL, 2008, 21 : 47 - 66
  • [45] The silent phase of diffuse low-grade gliomas. Is it when we missed the action?
    Pallud, Johan
    Capelle, Laurent
    Taillandier, Luc
    Badoual, Mathilde
    Duffau, Hugues
    Mandonnet, Emmanuel
    ACTA NEUROCHIRURGICA, 2013, 155 (12) : 2237 - 2242
  • [46] MALIGNANT TRANSFORMATION OF LOW-GRADE GLIOMAS. PROGNOSTIC IMPLICATIONS FROM MATHEMATICAL MODEL
    Bogdanska, M. U.
    Bodnar, M.
    Piotrowska, M. J.
    Murek, M.
    Schucht, P.
    Beck, J.
    Martinez-Gonzalez, A.
    Perez-Garcia, V. M.
    NEURO-ONCOLOGY, 2017, 19 : 85 - 85
  • [47] Predictive impact of IDH1 or IDH2 mutations on outcome and response to temozolomide in low-grade gliomas.
    Houillier, C.
    Wang, X.
    Kaloshi, G.
    Mokhtari, K.
    Laffaire, J.
    Boisselier, B.
    Idbaih, A.
    Hoang-Xuan, K.
    Sanson, M.
    Delattre, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] First results of radiotherapy after hyperbaric oxygenation with temozolomide for high-grade gliomas.
    Khelif, David Hamid
    Kintzinger, Clement
    Taha, Said
    Gauchez, Philippe
    Bintner, Marc
    Chirpaz, Emmanuel
    Harms, Jan-Dirk
    Magnin, Valerie Florence
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Retrospective review of safety and efficacy of checkpoint inhibition in refractory high-grade gliomas.
    Reiss, Samantha
    Yerram, Prakirthi
    Modelevsky, Lisa
    Grommes, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Neuropathological and molecular aspects of low-grade and high-grade gliomas
    Michotte, A
    Neyns, B
    Chaskis, C
    Sadones, J
    In't Veld, P
    ACTA NEUROLOGICA BELGICA, 2004, 104 (04) : 148 - 153
12345